Cas:3718-04-5 5-Vinyl-1H-imidazole manufacturer & supplier

We serve Chemical Name:5-Vinyl-1H-imidazole CAS:3718-04-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Vinyl-1H-imidazole

Chemical Name:5-Vinyl-1H-imidazole
CAS.NO:3718-04-5
Synonyms:1-Cyclohexene-1,4-dicarboxylic acid,4-ethenyl-,diethyl ester;4-Vinyl-cyclohex-1-en-1,4-dicarbonsaeure-diaethylester;4-vinyl-1H-imidazole;4-vinyl-cyclohex-1-ene-1,4-dicarboxylic acid diethyl ester;4-vinyl-1(3)H-imidazole;1-Vinyl-cyclohexen-(3)-dicarbonsaeure-(1,4)-diethylester;4-vinylimidazole;diethyl 4-vinylcyclohex-1-ene-1,4-dicarboxylate;4(5)-vinylimidazole;1-Vinyl-cyclohex-3-en-1,4-dicarbonsaeurediethylester;Diethyl 4-vinyl-cyclohex-1-en-1,4-dicarboxylat;4-Vinyl-1(3)H-imidazol
Molecular Formula:C5H6N2
Molecular Weight:94.11450
HS Code:2933290090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:28.68000
Exact Mass:94.05310
LogP:1.05270

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Cyclohexene-1,4-dicarboxylic acid,4-ethenyl-,diethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Vinyl-1(3)H-imidazol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Cyclohexene-1,4-dicarboxylic acid,4-ethenyl-,diethyl ester Use and application,1-Vinyl-cyclohexen-(3)-dicarbonsaeure-(1,4)-diethylester technical grade,usp/ep/jp grade.


Related News: The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. 3,3-dimethylpentan-1-ol manufacturers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. 1-(4-methylbenzyl)piperazine suppliers The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. 5-chloro-2-phenylpyrazole-3-carboxylic acid vendor & factory It now operates fourteen plants across four continents, including two in southern California it inherited from its $112 million acquisition of German plastic packaging firm Balda in 2016.,Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%.